- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
What We’re Reading: ADHD Medication Mix-Up; Surge in ACOs; Mifepristone Restrictions
Attention-deficit/hyperactivity disorder (ADHD) medication packets are found with incorrect pills; CMS data reveal record numbers of providers and beneficiaries participating in accountable care organizations (ACOs); Supreme Court will hear arguments over FDA regulations on abortion medication in March.
ADHD Medication Pulled From Shelves Amid Pill Mix-Up
Azurity Pharmaceuticals issued a recall for attention-deficit/hyperactivity disorder (ADHD) medication dextroamphetamine sulfate (Zenzedi) following the discovery of a potential mix-up in pill packaging, according to CNN. Concerns arose when reports surfaced of incorrect pills found in medication packets, prompting the company to take action to prevent any potential health risks. Patients and health care professionals have been urged to check their supplies and contact the company for guidance. A national shortage of ADHD drugs has been ongoing since the fall, leaving some patients unable to secure their needed medications.
Medicare Sees Surge in ACOs, but Challenges Remain
A record-breaking 13.4 million Medicare beneficiaries are now under the care of 122 accountable care organizations (ACOs) in the Realizing Equity, Access, and Community Health (REACH) Model and 481 ACOs in the Medicare Shared Savings Program, according to Axios. In a statement, the National Association of ACOs (NAACOS) applauded the growth facilitated by recent changes to support provider organizations in joining value-based care models. Despite this success, challenges persist, with NAACOS recommending that CMS implement policies to sustain ACO participation.
Supreme Court to Review Mifepristone Restrictions
The US Supreme Court has announced its schedule to review a crucial case regarding mifepristone, a drug used in medication abortions, with arguments slated for late March, according to Stat. The case challenges FDA restrictions that require in-person dispensing, particularly during the COVID-19 pandemic, reigniting the debate on women's access to abortion pills. The outcome of this legal battle is poised to have significant implications for reproductive rights, with potential ramifications for the accessibility of abortion services across the nation.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Mental Health Diagnoses, Care Challenges Rise Among US Youth, Report Finds
April 26th 2024While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Read More
